The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

In this video, Raj Chovatiya, MD, PhD, discusses the latest findings on the use of topical roflumilast in patients with ...

The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

Scalp to shins relief with expert tips - Itching to know what’s causing that scratch? Learn how hydration, barrier repair, ...

Treatment with guselkumab among patients with psoriasis does not contribute to the risk for or progression of liver fibrosis.

Natasha Nettles is a strong woman. She’s a mom, a makeup artist, and she also happens to have psoriasis. But she doesn’t let this one part of her life take her down. She doesn’t let it ...

She also recommends it for those dealing with psoriasis and seborrheic dermatitis on the scalp. When it comes to scalp serums and leave-in products you massage into your follicles, Lolis likes ...

Background: Psoriasis is a chronic inflammatory skin disease with a ... No remarkable difference was observed in terms of previous IL-17 failure (p = 0.103). The ratios of scalp and genital ...

If you have psoriasis, you may feel like this autoimmune disease is plenty to cope with all on its own. But unfortunately there are a number of other health issues linked to the condition.

Now, a study from Michel Gilliet's laboratory shows that the antimicrobial peptide LL37 is responsible for activation of pDCs in psoriasis. Knowing that pDCs are activated in psoriasis ...

Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis treated with icotrokinra achieved the study’s primary ...